Recent Headlines
Within Pharmaceuticals
HealthWare Systems’ Security Achieves SOC 2 Type I Certification
HealthWare Systems announces its achievement of SOC 2 Type I certification through the evaluation conducted by I.S. Partners, LLC. - June 14, 2023 - HealthWare Systems
NuvOx Announces Glioblastoma Patient Treatment for Phase IIb RESTORE Trial
NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, announced that it enrolled and treated the first subject in the Phase IIb RESTORE Trial for newly-diagnosed glioblastoma multiforme... - June 09, 2023 - NuvOx Pharma
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics has launched its new Single Radial Immunodiffusion Testing services for the biological industry. - June 09, 2023 - Creative Diagnostics
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics has launched a set of highly specific antibodies against FXIIIa/F13A1 for vascular diseases. - June 09, 2023 - Creative Diagnostics
U.S. Congressman Mike Lawler Speaks to Pharmaceutical Execs Regarding Disparities in Marketing to Underserved Ethnic Minorities
United States Congressman Michael Lawler delivered a message at the MMM Media Convene Conference: Multicultural Marketing: Pharma’s New Frontier. The Congressman cited the disparities in messaging to ethnic minorities by the pharmaceutical industry and called out government agencies for lack of oversight. - June 08, 2023 - Emerging Networks
Hemanext Announces a Strategic Partnership and Investment from Vitalant
Partnership to include research and development at Vitalant Innovation Center. - June 07, 2023 - Hemanext
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
Dr. Jennifer Ripton-Snyder Joins New York Imaging Specialists
New York Imaging Specialists is thrilled to announce the addition of Dr. Jennifer Ripton-Snyder, a fellowship-trained breast imager. Dr. Ripton-Snyder will practice at 118 North Country Rd., Port Jefferson, NY 11777. “Dr. Ripton-Snyder’s expertise in Breast Imaging and her dedication... - June 06, 2023 - New York Imaging Specialists
GenInvo Part of PHUSE US Connect & Informa Connect Clinical Data Disclosure, Transparency & Plain Language Summaries Event - 2023
GENINVO was a part of 2 recent global events for the life science industry. The first was "PHUSE US Connect 2023" which was held in Renaissance Orlando at SeaWorld Florida on 5th – 8th March 2023 and the second event, Informa Connect Clinical Data Disclosure, Transparency &... - June 05, 2023 - GenInvo, Inc.
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
Sonar Clinical Research Diversity in Clinical Trials Summit Signifies a Significant Achievement in Promoting Healthcare Equity Within the Community
The Diversity in Clinical Trials Summit, held on April 22nd 2023, at The Gathering Spot, Atlanta Ga proved to be an extraordinary community event focused on promoting diversity and inclusion within the field of clinical research. The summit brought together renowned experts, thought leaders,... - June 04, 2023 - Sonar Clinical Research
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
Percept Sponsors Major Latin American Headache Symposium
Science behind MiWear™ to be presented by International Experts - May 26, 2023 - Percept
OPTI•MIST® Introduces Innovative Organic Personal Care Products
OPTI•MIST® Organic Introduces Innovative Organic Personal Care Products Infused with a Powerful Mineral-Based Antiseptic for Enhanced Hygiene. OPTI•MIST, a pioneering brand in the personal care industry, is pleased to announce the launch of its revolutionary line of organic personal... - May 26, 2023 - OPTI-LAB INC.
AcceleDev Celebrates Its 20 Year Anniversary
AcceleDev Chemical LLC, a leading strategic supplier of Pharmaceutical process custom synthesis services, is proud to celebrate its 20th Anniversary this month. Since its inception in 2003, AcceleDev has remained focused on helping pharmaceutical and biotech companies deliver life-saving... - May 25, 2023 - AcceleDev Chemical LLC
Hemanext Continues European Rollout of Hemanext ONE® RBC Processing and Storage System
Groundbreaking technology to be deployed to transfuse thalassemia patients in Italy and acute bleeding burn patients in Norway. - May 25, 2023 - Hemanext
Exclusive Event: Suggestic Unveils WellnessGPT, the Revolutionary AI-Powered Telewellness and Behavioral Engagement Platform
Suggestic, the leading provider of AI-enabled Telewellness solutions, is excited to announce an exclusive event on Tuesday, May 30, 2023. Join them to explore the challenges and opportunities of generative AI and witness the unveiling of WellnessGPT, Suggestic's revolutionary AI-powered Tele-wellness and Behavioral Engagement platform. - May 25, 2023 - Suggestic
The IEC Group Names the Top 25 Global EOR Providers Globally
Global employer of record (EOR) services have become crucial in facilitating expansion plans and business roadmaps in numerous enterprise industry verticals. The 2023 Global EOR Dynamic Map™ Study identified over 800 EOR companies, invited 102 companies for the detailed analysis, and awarded the top 25 providers as IEC Elite Members. - May 24, 2023 - The IEC Group
Suggestic Acquires Wishroute to Accelerate AI-Assisted Wellness Coaching Offering
Suggestic, a leading provider of AI-enabled Telewellness solutions, today announced that it has acquired Wishroute, a leading provider of human-powered engagement and healthy habit coaching. The acquisition allows Suggestic to expand its product and service offerings, enter new markets, and... - May 23, 2023 - Suggestic
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics recently introduced a series of Viral Replicon Assay services to assist researchers in identifying and studying viruses. - May 20, 2023 - Creative Diagnostics
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics, a leading global supplier of raw materials, antibodies, and reagents to the biotechnology industry, is proud to announce the launch of its new line of Calprotectin Reagents for the study of inflammation disease. Calprotectin is an abundant inflammatory marker in the... - May 20, 2023 - Creative Diagnostics
The Inc. Magazine, USA Includes Paras Biopharma (Biologics CDMO) as One of the Top 10 Most Innovative Biotech Companies to Follow in 2023
Paras Biopharma (Biologics CDMO), a biopharmaceutical technology development company is pleased to be included by The Inc. Magazine, USA as “One of the Top 10 Most Innovative Biotech Companies to Follow in 2023.” The Inc. Magazine serves as an online "go-to" informative tool for business leaders and entrepreneurs, including CEOs and owners of small-to-midsize companies to success, providing news, advice, and inspirational articles. - May 19, 2023 - Paras Biopharmaceuticals Finland Oy
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
PF Consulting Firm #1 Credentialing and Medical Billing Services of 2023
PF Consulting Firm: Empowering Healthcare Practices with Comprehensive Solutions - May 18, 2023 - PF Consulting Firm
PharmStars Announces Spring 2023 Startup Showcase Event Underway
PharmStars, the pharma-focused accelerator for digital health startups, announces that its fourth Showcase Event begins May 16, 2023. The Showcase is the culmination of the Spring 2023 10-week accelerator program. At the Showcase, each startup in the fourth cohort makes a formal presentation to and meets individually with PharmStars’ pharma members. The theme of the Spring 2023 program is digital innovations in women’s health or health equity. - May 16, 2023 - PharmStars
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
LAST Skincare Unveils Upgraded Skin Repair Serum with 35+ Potent Ingredients for Profound Skin Regeneration
LAST Skincare, the brand known for its uncompromising approach to delivering clinically proven formulations that regenerate and restructure the skin, has launched an upgraded version of its signature Skin Repair Serum after two years of further research and testing. The new formula boasts 35+ plant and science-based active ingredients, including botanical alternatives to retinol, adaptogens, biomimetic tetrapeptides and peptides, cold-pressed oils, glycerides, vitamins, bioferments and more. - May 15, 2023 - LAST Skincare
ProCanna Launches Its Cannabis Compliance and Operational Solution in Missouri
ProCanna expands into fifteenth market. - May 13, 2023 - ProCanna
Brown & Barron Promotes Emily “E.J.” Hammann to Partner
Emily “E.J.” Hammann has been promoted to Partner at Brown & Barron, LLC, a Baltimore-based law firm specializing in nursing home negligence, birth injury, and medical malpractice. Ms. Hammann is among the profession’s most respected litigators of complex and formidable... - May 11, 2023 - Brown & Barron
Creative Biolabs: Going Above and Beyond to Advance Immunology Discovery
Creative Biolabs updated strategies in order to help achieve success in immunotherapy discovery. - May 10, 2023 - Creative Biolabs
Parvus Therapeutics Announces a Publication Describing the Cellular Origin of Treg Cells Generated Endogenously by Navacim Therapy
Parvus Therapeutics announced today the publication of data showing that peptide-MHC class II-coated nanoparticles (Navacims) operate by triggering the expansion of cognate T follicular helper (TFH) cells. - May 09, 2023 - Parvus Therapeutics U.S., Inc.
North American Pet Insurance Industry Surpasses $3.5 Billion
The North American Pet Health Insurance Association (NAPHIA) today released its 2023 State of the Industry (SOI) Report showing the North American pet health insurance sector grew by 23.5% in In-Force GWP over 2022. This year’s SOI Report highlights a number of noteworthy industry... - May 04, 2023 - NAPHIA - North American Pet Health Insurance Association
Micro Merchant Systems Wins Stevie Award® for Outstanding Product Innovation in the 2023 American Business Awards®
Micro Merchant Systems, Inc., developer of the PrimeRx™ pharmacy technology management system, has been recognized for “Achievement in Product Innovation” and awarded a bronze Stevie® Award in the 2023 American Business Awards® competition. - May 04, 2023 - Micro Merchant Systems
Vision Industry Leaders Join Percept Corporation
Dr. Alan Glazier and Dr. Dorothy Hitchmoth to Lead Vision Technology/Clinical Expansion in Augmented Perception™ - May 03, 2023 - Percept
Cyclists Ride Through MA, NH, and ME in Tri-State Trek to Benefit ALS Research
June 24-25, cyclists of all levels are invited to participate in the Tri-State Trek, a New England cycling event raising funds for cutting-edge research to end ALS. - May 03, 2023 - ALS Therapy Development Institute
New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. - April 30, 2023 - Cayman Chemical Company
Liberum Independent Medical Education Announces Management Buyout
Liberum Independent Medical Education, provider of independent medical education (IME) to healthcare professionals worldwide, has announced a management buyout (MBO) from its original owner, OHC London Holdings Ltd. The MBO was led by the company's Managing Director, Celeste Kolanko who has taken ownership of the company which now operates as Liberum IME BV, and Liberum Independent Medical Education Ltd. - April 29, 2023 - Liberum Independent Medical Education Ltd
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics recently introduced a new line of low endotoxin antibodies to biopharmaceutical research laboratories. - April 29, 2023 - Creative Diagnostics
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics introduced the Virus Yield Reduction Assay Service to support researchers in evaluating the antiviral activity of compounds. - April 29, 2023 - Creative Diagnostics
NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe
NanoCellect Biomedical, the leading provider of microfluidic flow cytometry platforms, has announced new distributor partnerships in Asia and Europe to expand its global reach and provide greater accessibility to its innovative technologies. - April 26, 2023 - NanoCellect Biomedical
How to Select the Right Load Movement System - Podcast Now Available
AeroGo, manufacturer of innovative load moving equipment, launched a new seven-episode podcast, called, "Select the Right Load Movement System." Each episode covers a specific question used to narrow down the choices available to the listener’s situation. - April 26, 2023 - AeroGo, Inc.
Kindness of Strangers Contributing Free Community Service Hours Helps Young Woman Pay for Life-Changing Surgery Through M25 Program as Featured on CNN
Ashley Smith, from Lakeland, Florida, needs a life-changing surgery to cure migraines from Occipital Neuralgia. Demetrio Aguila, MD is a pain-focused peripheral nerve surgeon who can eliminate her pain. To pay for the surgery, Ashley needs financial help. Dr. Aguila created the M25 Program where patients can finance their care with community service hours. Two strangers in tiny Elgin, Nebraska contributed more than 300 hours of community service to help Ashley reach her goal. - April 26, 2023 - Total Pain Solutions
Fight ALS Film Fest Aims to Continue the Momentum to Beat ALS
The second annual Festival will explore universal themes of life-changing diseases through examination of ALS. - April 26, 2023 - ALS Therapy Development Institute
Brain Tumor Investment Fund Names Managing Director
National Brain Tumor Society’s venture philanthropy affiliate appoints industry veteran to lead fund designed to invest in and accelerate development of promising new technologies for patients with brain cancer. - April 26, 2023 - National Brain Tumor Society
NuvOx Receives SPAN Grant
NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with Reperfusion - April 24, 2023 - NuvOx Pharma
Johari Digital Makes a Significant Contribution from Their CSR Fund to Support Innovation, Research & Incubation at IIT, Jodhpur
As a part of the Industry and Academia collaboration, Johari Digital Healthcare Ltd. donated a significant funding amount to IIT, Jodhpur Incubation & Innovation center from their CSR Fund to boost & strengthen Med-Tech Startup Ecosystem. Mr. Satyendra Johari, Executive Chairman &... - April 24, 2023 - Johari Digital Healthcare Ltd.
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
Creative Biolabs Provides Full-Fledged Solutions for Progressive Exosome Research
A newly released market research reports on the prosperous future of exosome research. - April 14, 2023 - Creative Biolabs
DistillerSR Appoints New Board Members to Accelerate Scaleup and Healthcare Analytics Domain Expertise
DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today welcomed Dr. Khaled El Emam and Jason Flick as new board members. The two serial entrepreneurs join Andrew Pinkerton, Partner at Thomvest Ventures, Maria Pacella,... - April 11, 2023 - DistillerSR